NCBI Taxonomy: 35754

Dactylosporangium aurantiacum (ncbi_taxid: 35754)

found 3 associated metabolites at species taxonomy rank level.

Ancestor: Dactylosporangium

Child Taxonomies: Dactylosporangium aurantiacum subsp. hamdenensis

Lipiarmycin

Lipiarmycin

C52H74Cl2O18 (1056.4251964)


A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07A - Intestinal antiinfectives > A07AA - Antibiotics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C784 - Protein Synthesis Inhibitor > C261 - Macrolide Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic Fidaxomicin (OPT-80), a macrocyclic antibiotic, is an orally active and potent RNA polymerase inhibitor. Fidaxomicin has a narrow spectrum of antibacterial activity and a good anti-Clostridium difficile activity (MIC90=0.12?μg/mL). Fidaxomicin can be used for Clostridium difficile infection (CDI) research[1][2][3].

   

(2s,3r,4r,5r,6s)-6-{[(3z,5z,9z,13z,15z)-12-{[(2r,3s,4s,5s)-4,5-dihydroxy-6,6-dimethyl-3-[(2-methylpropanoyl)oxy]oxan-2-yl]oxy}-11-ethyl-8-hydroxy-18-(1-hydroxyethyl)-9,13,15-trimethyl-2-oxo-1-oxacyclooctadeca-3,5,9,13,15-pentaen-3-yl]methoxy}-4-hydroxy-5-methoxy-2-methyloxan-3-yl 3-bromo-6-ethyl-2,4-dihydroxybenzoate

(2s,3r,4r,5r,6s)-6-{[(3z,5z,9z,13z,15z)-12-{[(2r,3s,4s,5s)-4,5-dihydroxy-6,6-dimethyl-3-[(2-methylpropanoyl)oxy]oxan-2-yl]oxy}-11-ethyl-8-hydroxy-18-(1-hydroxyethyl)-9,13,15-trimethyl-2-oxo-1-oxacyclooctadeca-3,5,9,13,15-pentaen-3-yl]methoxy}-4-hydroxy-5-methoxy-2-methyloxan-3-yl 3-bromo-6-ethyl-2,4-dihydroxybenzoate

C52H75BrO18 (1066.413651)